FDA Inspection 1266388 — Covenant Medical Center

Covenant Medical Center — FEI 1671229

The FDA completed an inspection of Covenant Medical Center on April 3, 2025 in Lubbock, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 3, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lubbock, TX (United States)